Proteomics

Dataset Information

0

A549 treated with CISPLATIN/TSA VS CONTROL


ABSTRACT: WE TEST THE PROTEIN CHANGES WHEN A549 cells treated with DDP OR TSA.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture, Early Embryonic Cell

DISEASE(S): Colon Cancer

SUBMITTER: Yang Zhou  

LAB HEAD: Zhou Yang

PROVIDER: PXD052305 | Pride | 2024-06-23

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
1-1.raw Raw
1-10.raw Raw
1-11.raw Raw
1-12.raw Raw
1-2.raw Raw
Items per page:
1 - 5 of 37
altmetric image

Publications

Trichostatin A Promotes Cytotoxicity of Cisplatin, as Evidenced by Enhanced Apoptosis/Cell Death Markers.

Zhou Yang Y   Luo Qun Q   Zeng Fangang F   Liu Xingkai X   Han Juanjuan J   Gu Liangzhen L   Tian Xiao X   Zhang Yanyan Y   Zhao Yao Y   Wang Fuyi F  

Molecules (Basel, Switzerland) 20240603 11


Trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, promotes the cytotoxicity of the genotoxic anticancer drug cisplatin, yet the underlying mechanism remains poorly understood. Herein, we revealed that TSA at a low concentration (1 μM) promoted the cisplatin-induced activation of caspase-3/6, which, in turn, increased the level of cleaved PARP1 and degraded lamin A&C, leading to more cisplatin-induced apoptosis and G2/M phase arrest of A549 cancer cells. Both ICP-MS and ToF-SIMS measu  ...[more]

Similar Datasets

2024-06-23 | PXD052203 | Pride
2019-10-23 | PXD015469 | Pride
2012-06-30 | E-MTAB-796 | biostudies-arrayexpress
2022-08-22 | PXD031593 | Pride
2024-09-17 | PXD055943 | Pride
2011-07-06 | E-GEOD-30404 | biostudies-arrayexpress
2023-05-17 | PXD038853 | Pride
2011-08-22 | E-GEOD-27604 | biostudies-arrayexpress
2021-08-16 | PXD022969 | Pride
2022-02-15 | PXD028363 | Pride